Tag: exa-cel insurance coverage requirements
Casgevy (exa-cel) 2024 FDA Approval: Complete Guide to Adult Side Effects, Eligibility Age, Insurance Coverage & Sickle Cell Gene Therapy Cost
July 2024 | Citing 2024 FDA, CDC, and American Society of Hematology data, this complete Casgevy (exa-cel) buying guide breaks down key details for eligible sickle cell disease patients. Comparing premium FDA-regulated Casgevy vs unregulated counterfeit overseas CRISPR treatments, 94% of eligible U.S. patients aged 12+ see zero severe vaso-occlusive crises for 2+ years post-treatment.